Bionomics Limited (BNOX)
0.2531
+0.0110 (4.59%)
Inactive · Last trade price on Dec 23, 2024

Bionomics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Revenue
---6.060.932.99
Revenue Growth
---552.46%-68.98%-59.37%
Gross Profit
----9.94-4.83-2.84
Operating Income
-15.9-17.8-21.56-17.6-10.28-7.49
Net Income
-10.82-15.49-21.38-21.76-8.7-7.12
Earnings Per Share
-0.92-1.55-2.62-3.60-2.01-2.35
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Cash & Investments
8.0812.6112.133.5628.54.58
Total Debt
0.220.240.350.690.8712.24
Net Cash (Debt)
7.8612.3711.7532.8727.63-7.66
Net Cash Growth
-33.08%5.27%-64.26%18.96%--
Net Cash Per Share
0.671.241.444.376.38-2.53

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Operating Cash Flow
-14.68-14.68-14.64-21.76-7.54-3.9
Capital Expenditures
----0-0-0.01
Free Cash Flow
-14.68-14.68-14.64-21.76-7.54-3.91
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Gross Margin
----164.21%--94.76%
Operating Margin
----290.62%-1107.29%-250.19%
Pretax Margin
----362.51%-957.30%-201.41%
Profit Margin
----359.34%-937.11%-237.89%
FCF Margin
----359.30%-812.46%-130.70%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
PS Ratio
---8.68--